Crystals and arthritis (2022)

Table of Contents
Disease-a-Month Abstract References (117) Semin Arthritis Rheum Rheum Dis Clin North Am Exp Cell Res Matrix Am J Med Lancet The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudogout syndrome”. I. Clinical aspects Ann Intern Med Identification of urate crystals in gouty synovial fluid Ann Intern Med Pathological tissue calcifications in man Arch Pathol Studies on pathological calcifications in human cartilage. I. Prevalence and types of crystal deposits in menisci of two hundred fifteen cadavers J Bone Joint Surg Crystal populations in human synovial fluid The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudogout syndrome”. II. Identification of crystals Ann Intern Med Preparation and characterization of some calcium pyrophosphates J Agricult Food Chem Zur pathologie und therapie der zwischenknorpelerkrankungen des kniegelenks Arch Klin Chir Abnorme kalkblagerungen inner halb des kniegelenks, ein betrag zur frage der primen meniskopathie Fortschr Boentgenstr Nuclear Med Articular chondrocalcinosis Ann Rheumat Dis Abnormal deposits in joints Dublin J Med Sci The inflammatory reaction to sodium urate JAMA Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response J Exp Med Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes J Exp Med Studies on the nature of gouty tophi, an abridged translation with comments by Freudweiler M and His W, 1899 Ann Intern Med Translation of experimental investigations into the origin of gouty tophi by Freudweiler M Arthritis Rheum A historical note: Leeuwenhoek's description of crystals from a gouty tophus Arthritis Rheum Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals: relationship to the pathogenesis of crystal-induced inflammation Arthritis Rheum Protein binding to monosodium urate monohydrate, calcium pyrophosphate and silicon dioxide crystals I. Physical characteristics J Lab Clin Med Protein binding to monosodium urate crystals and its effect on platelet degranulation Adv Exp Med The release of platelet constituents by monosodium urate crystals J Clin Invest Molecular orientation of immunoglobulin G absorbed to microcrystalline monosodium urate monohydrate J Lab Clin Med Plasma protein binding by monosodium urate crystals: analysis by two-dimensional gel electrophoresis Arthritis Rheum Immunoglobulin G independent activation of the classical complement pathway by sodium urate crystals J Clin Invest Effects of IgG and c-reactive protein on complement depletion by monosodium urate crystals J Rheumatol Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate J Exp Med Kinetics of collagenase and neutral protease release by neutrophils exposed to microcrystalline sodium urate Connect Tissue Res Mechanisms of lysosomal enzyme release from leukocytes IV interaction of monosodium urate crystals with dogfish and human leukocytes Arthritis Rheum Crystal induced arthritis Postgrad Med Polymorphonuclear leukocyte motility in vitro III. Possible release of chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes Arthritis Rheum Demonstration of chemotactic factor in human gout J Rheumatol Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor J Clin Invest Polymorphonuclear leukocytes motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals Arthritis Rheum Colchicine prevents recurrent pseudogout Arthritis Rheum Colchicine prophylaxis in pseudogout J Rheumalol Colchicine and pseudogout Arthritis Rheum Colchicine in acute gout JAMA Pathogenesis and treatment of crystal-induced inflammation Synovial Fluid Gout without hyperuricemia JAMA Serum and urinary uric acid The influence of temperature on the solubility of monosodium urate Arthritis Rheum Cited by (61) Recommended articles (6) FAQs Videos
ScienceDirect

Corporate sign inSign in / register

ViewPDF

  • Access throughyour institution

Disease-a-Month

Volume 40, Issue 6,

June 1994

, Pages 258-299

Abstract

Monosodium urate, calcium pyrophosphate dihydrate, and basic calcium phosphate (carbonate-substituted hydroxyapatite and octacalcium phosphate) crystal aggregates are associated with gout, pseudogout, and cartilage degeneration (osteoarthritis, Milwaukee Shoulder/Knee Syndrome), respectively. Hyperuricemia is a frequent but nonspecific and inconstant feature of gout just as an elevated synovial fluid inorganic pyrophosphate level is an inconstant feature of pseudogout. Monosodium urate, calcium pyrophosphate dihydrate, or basic calcium phosphate crystals can cause acute inflammation associated with phagocytosis by neutrophilic leukocytes. Each induces neutral protease synthesis and secretion and arachidonic acid metabolism by synoviocytes and macrophages in a dose-dependent fashion, postulated to produce the damage to bone, cartilage, and other joint tissues that is perceived clinically as tophaceous destruction or degenerative joint disease. Crystals containing calcium are potent mitogens. All three types of crystals are more common in older persons and will attract additional attention as the mean age of our population increases. Gout is perhaps the most treatable disease in medicine, although mistakes in diagnosis and in choice of appropriate therapy are very common. Acute pseudogout and acute calcific periarthritis are readily treated medically, but the chronic effects of crystals containing calcium are not. New approaches using drugs derived from scientific study of the biologic effects of these crystals may become useful therapeutically.

References (117)

  • SY Ali et al.New types of calcium phosphate crystals in arthritis cartilage

    Semin Arthritis Rheum

    (1981)

  • HS Cheung et al.Mechanisms of connective tissue damage by crystals

    Rheum Dis Clin North Am

    (1988)

  • HS Cheung et al.Mitogenesis induced by calcium-containing crystals: Role of intracellular dissolution

    Exp Cell Res

    (1985)

  • LM Ryan et al.Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate

    Matrix

    (1991)

  • NM Hadler et al.Acute polyarticular gout

    Am J Med

    (1974)

  • JS Faires et al.Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals

    (Video) Crystals for Arthritis & Joint Pain

    Lancet

    (1962)

  • DJ McCarty et al.

    The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudogout syndrome”. I. Clinical aspects

    Ann Intern Med

    (1962)

  • DJ McCarty et al.

    Identification of urate crystals in gouty synovial fluid

    Ann Intern Med

    (1961)

  • RA Gatter et al.

    Pathological tissue calcifications in man

    Arch Pathol

    (1967)

  • DJ McCarty et al.

    Studies on pathological calcifications in human cartilage. I. Prevalence and types of crystal deposits in menisci of two hundred fifteen cadavers

    J Bone Joint Surg

    (1966)

  • DJ McCarty et al.

    Crystal populations in human synovial fluid

  • NN Kohn et al.

    The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudogout syndrome”. II. Identification of crystals

    Ann Intern Med

    (1962)

  • EH Brown et al.

    Preparation and characterization of some calcium pyrophosphates

    J Agricult Food Chem

    (1963)

  • F Mandl

    Zur pathologie und therapie der zwischenknorpelerkrankungen des kniegelenks

    Arch Klin Chir

    (1927)

  • K Werwath

    Abnorme kalkblagerungen inner halb des kniegelenks, ein betrag zur frage der primen meniskopathie

    Fortschr Boentgenstr Nuclear Med

    (1928)

  • D Zitnan et al.

    Articular chondrocalcinosis

    Ann Rheumat Dis

    (1963)

  • EH Bennett

    Abnormal deposits in joints

    Dublin J Med Sci

    (1903)

  • McCarty DJ. Phagocytosis of urate crystals in gouty synovial fluid. Am J Med Sci...
  • JF Seegmiller et al.

    The inflammatory reaction to sodium urate

    JAMA

    (1962)

  • DJ McCarty et al.

    Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response

    J Exp Med

    (1966)

  • P Phelps et al.

    Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes

    J Exp Med

    (1966)

  • JM Brill et al.

    Studies on the nature of gouty tophi, an abridged translation with comments by Freudweiler M and His W, 1899

    Ann Intern Med

    (1964)

  • JM Brill et al.

    Translation of experimental investigations into the origin of gouty tophi by Freudweiler M

    Arthritis Rheum

    (1965)

  • DJ McCarty

    A historical note: Leeuwenhoek's description of crystals from a gouty tophus

    Arthritis Rheum

    (1970)

  • F Kozin et al.

    Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate, and silica crystals: relationship to the pathogenesis of crystal-induced inflammation

    Arthritis Rheum

    (1976)

  • F Kozin et al.

    Protein binding to monosodium urate monohydrate, calcium pyrophosphate and silicon dioxide crystals I. Physical characteristics

    J Lab Clin Med

    (1977)

  • F Kozin et al.

    Protein binding to monosodium urate crystals and its effect on platelet degranulation

    Adv Exp Med

    (1976)

  • MH Ginsberg et al.

    The release of platelet constituents by monosodium urate crystals

    J Clin Invest

    (1977)

  • F Kozin et al.

    Molecular orientation of immunoglobulin G absorbed to microcrystalline monosodium urate monohydrate

    (Video) Best Crystals for Arthritis Pain

    J Lab Clin Med

    (1980)

  • R Terkeltaub et al.

    Plasma protein binding by monosodium urate crystals: analysis by two-dimensional gel electrophoresis

    Arthritis Rheum

    (1983)

  • PC Giclas et al.

    Immunoglobulin G independent activation of the classical complement pathway by sodium urate crystals

    J Clin Invest

    (1979)

  • IJ Russell et al.

    Effects of IgG and c-reactive protein on complement depletion by monosodium urate crystals

    J Rheumatol

    (1983)

  • WR Wallingford et al.

    Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate

    J Exp Med

    (1971)

  • H Cheung et al.

    Kinetics of collagenase and neutral protease release by neutrophils exposed to microcrystalline sodium urate

    Connect Tissue Res

    (1983)

  • S Hoffstein et al.

    Mechanisms of lysosomal enzyme release from leukocytes IV interaction of monosodium urate crystals with dogfish and human leukocytes

    Arthritis Rheum

    (1975)

  • P Phelps et al.

    Crystal induced arthritis

    Postgrad Med

    (1969)

  • P Phelps

    Polymorphonuclear leukocyte motility in vitro III. Possible release of chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes

    Arthritis Rheum

    (1969)

  • P Phelps et al.

    Demonstration of chemotactic factor in human gout

    J Rheumatol

    (1981)

  • I Spilberg et al.

    Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor

    J Clin Invest

    (1979)

  • P Phelps

    Polymorphonuclear leukocytes motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals

    Arthritis Rheum

    (1970)

  • I Krakoff
  • C Bowles

    Colchicine prevents recurrent pseudogout

    Arthritis Rheum

    (1986)

  • A Alvarellos et al.

    Colchicine prophylaxis in pseudogout

    J Rheumalol

    (1986)

  • I Spilberg et al.

    Colchicine and pseudogout

    Arthritis Rheum

    (1980)

  • WM Roberts et al.

    Colchicine in acute gout

    JAMA

    (1987)

  • RA Terkeltaub

    Pathogenesis and treatment of crystal-induced inflammation

  • DJ McCarty

    Synovial Fluid

  • DJ McCarty

    Gout without hyperuricemia

    JAMA

    (1994)

  • DJ McCarty et al.

    Serum and urinary uric acid

  • JN Loeb

    The influence of temperature on the solubility of monosodium urate

    Arthritis Rheum

    (1972)

  • Cited by (61)

    • Dexamethasone causes calcium deposition and degeneration in human anterior cruciate ligament cells through endoplasmic reticulum stress

      2020, Biochemical Pharmacology

      Dexamethasone is widely used in the treatment of joint diseases due to its anti-inflammatory properties. However, it can cause serious adverse effects. The anterior cruciate ligament (ACL) is an important stabilizer of the knee joint. However, the effect of dexamethasone treatment on the ACL is unclear.

      This study aims to explore the effects of dexamethasone on ACL tissues and cells through in vitro and in vivo experiments.

      In vitro, we found that after treatment with dexamethasone, human ACL cell apoptosis was increased, type I collagen (COL1A1) content was decreased, mineralization related genes (ENPP1 and ANKH) and calcified nodules were increased, and endoplasmic reticulum stress (ERS) was enhanced. However, ERS inhibitors could significantly inhibit the increase in calcification and the decrease in COL1A1 induced by dexamethasone. In vivo, Wistar rats received the infra-articular injection with dexamethasone (0.5mg/kg) for 8weeks. We found that dexamethasone treatment decreased the COL1A1 content and increased the COL2A1 content in the ACL tissues of rats and that chondroid differentiation and mineralization occurred. Meanwhile, the expression of ERS-related proteins was increased.

      Dexamethasone increased the calcification of ACL cells and caused ACL degeneration through ERS, suggesting that long-term treatment with dexamethasone may cause adverse effects on ACL tissue and increase the risk of long-term rupture.

      (Video) Gout Vs Pseudogout Vs Hydroxyapatite Arthropathy
    • Calcium Pyrophosphate Dihydrate Deposition Disease

      2015, Mineral Scales and Deposits: Scientific and Technological Approaches

      Development and deposition of amorphous or crystalline inorganic phases, a process referred to as mineralization, occur in a large numbers of biological systems. In the human body, physiological mineralization is vital for the development and maintenance of the skeleton. However, crystals are often formed and accumulated in various other sites of the body as a result of metabolic disorders. Calcium pyrophosphate dihydrate, is among the most common types of pathological deposits and the condition associated with the presence of such crystals is referred to as calcium pyrophosphate (dihydrate) deposition disease. This chapter discusses the current knowledge regarding calcium pyrophosphate deposition disease and further focuses on the characterization methods and the in vitro model systems for studying the conditions under which these crystals develop.

    • Imaging in the crystal arthropathies

      2014, Rheumatic Disease Clinics of North America

      These findings highlight the unique nature of the osteopathology of gout, which contrasts with that of immune-mediated arthropathies such as RA. CPPD crystal deposition disease is a common form of crystalline arthropathy characterized clinically by a variety of patterns including the most common asymptomatic state (radiographic chondrocalcinosis, Fig. 7), acute monoarthritis (pseudogout), and a symmetric polyarticular destructive arthropathy that mimics RA.56 A formal diagnosis of CPPD crystal deposition disease requires synovial fluid analysis and the finding of typical rhomboidal crystals with specific birefringence characteristics.

    • Endoscopic treatment of calcific tendinitis of the rectus femoris in a patient with intractable pain

      2013, Journal of Orthopaedic Science

    • Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases

      2010, Seminars in Arthritis and Rheumatism

      To evaluate the efficacy of anakinra for patients with acute gout.

      We reviewed the charts of 10 patients who received anakinra for urate crystal-induced arthritis at the Hospital for Special Surgery since 2007. Demographic information, comorbidities, short-term treatment outcomes, and subsequent flares were reviewed.

      Patients in our study had a high prevalence of comorbidities. All patients received corticosteroids before anakinra treatment. The mean number of anakinra injections was 3.2 per patient (100 mg subcutaneously per day). Six patients had a good response. Three patients had a partial response and 1 patient had no response. Nine patients had documented recurrent flares after discontinuing anakinra (ranging from 3 to 45 days after).

      Anakinra is a therapeutic option for patients with acute urate crystal-induced arthritis who do not respond to or have a contraindication to traditional treatments. Although a short course of anakinra resulted in favorable outcomes for some of our patients, response rates were poorer in our study than in previously published reports, and relapses were common.

    • Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response

      2007, International Immunopharmacology

      Polymethylmethacrylate (PMMA) particles generated by the breakdown of implanted prosthetics, such as the articulating surfaces of hip or knee replacements, migrate into various tissues and lead to activation of the host's inflammatory and immune responses [16]. In crystal deposition diseases such as arthritis and gout, it is the crystals of calcium pyrophosphate dihydrate (CPPD) or monosodium urate monohydrate (MSUM) that instigate painful acute inflammation after phagocytosis [15,17]. Basic calcium phosphate crystals (BCP, various admixtures of hydroxyapatite (HAP), octacalcium phosphate and tricalcium phosphate) are the particulates associated with the inflammation of osteoarthritis [18].

      The influence of the physico-chemical features of particulates made of calcium phosphate (hydroxyapatite, HAP) crystals, or monosodium urate monohydrate (MSUM) crystals, on the innate immune response was investigated in mice after intraperitoneal injections. The phenotype and activation status of harvested peritoneal cells from C57BL/6 mice was determined by flow cytometry analysis at 24, 48 and 72h after particulate injections and compared to a known adjuvant, aluminum phosphate (ALP). A rigorous characterization of the chemistry, structure, morphology and particle size of the particulates was completed. Mid-sized (10μm mean size) particulates of both crystal types recruited the most cells, as compared to fine (1μm) or large (100μm) particulates. Analysis of sub-populations of the peritoneal cells revealed that MSUM induced fewer PMNs and eosinophils than HAP or ALP. MSUM also had the greatest effect on the expression of CD11b, MHC-Class II and CD86 on peritoneal macrophages indicating MSUM provides a robust antigen presenting and co-stimulatory bridge between the innate and adaptive immune systems. This study indicates that manipulation of the physico-chemical features of particulates is a means of controlling the innate immune response and that knife-like morphologies are more stimulatory than spherical or plate-like shapes. Proper utilization of the physico-chemical features of particulates offers a new direction for the development of more effective vaccine adjuvants.

    View all citing articles on Scopus

    Recommended articles (6)

    • Research article

      An Uncharted Constellation: TAFRO Syndrome

      The American Journal of Medicine, Volume 129, Issue 9, 2016, pp. 938-941

    • Research article

      Primary sclerosing cholangitis

      Medicine, Volume 43, Issue 11, 2015, pp. 648-652

      (Video) Gout - causes, symptoms, diagnosis, treatment, pathology

      Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease caused by diffuse inflammation and fibrosis that can involve the entire biliary tree. The progressive pathological process obliterates intrahepatic and extrahepatic bile ducts, leading ultimately to biliary cirrhosis, portal hypertension and hepatic failure.

      The cause is unknown but it is closely associated with inflammatory bowel disease, particularly ulcerative colitis, which occurs in about 70% of cases. Approximately 5–10% of patients with total ulcerative colitis will have co-existing PSC.

      Clinical symptoms include fatigue, intermittent jaundice, weight loss, right upper-quadrant abdominal pain and pruritus. The clinical course of PSC is variable. Serum biochemical tests usually indicate cholestasis; the diagnosis is established by cholangiography.

      In symptomatic patients, median survival from presentation to death or liver transplantation is about 12 years. About 75% of asymptomatic patients survive 20 years or more. Median overall survival is 23 years. Overall, 37% of patients die from hepatic failure, while approximately 44% die from cancer – PSC is a premalignant condition. The commonest malignancy is hepatobiliary in origin, usually bile duct carcinoma, which is often aggressive. Patients with associated inflammatory bowel disease may die from colonic cancer or complications of colitis.

      PSC has no curative treatment. Medical treatment with the bile acid, ursodeoxycholic acid, may slow progression of the disease and act as a chemoprotective agent against colonic dysplasia. Liver transplantation is the only option in young patients with PSC and advanced liver disease; 5-year survival is 80–90% in most centres. The disease will recur in the donor liver in 30% of patients after 5 years.

    • Research article

      Autoimmune hepatitis and overlap syndromes

      Medicine, Volume 43, Issue 11, 2015, pp. 639-644

      Autoimmune hepatitis (AIH) is a progressive necro-inflammatory liver disease associated with significant morbidity and mortality. It affects mainly females and has a varied clinical presentation from minor symptomatology to acute liver failure. The diagnosis should be considered in anyone with abnormal liver function tests. Diagnostic features include biochemical evidence of transaminitis, elevated immunoglobulin G and positive autoantibodies. Liver biopsy may show interface hepatitis with portal-based plasma cell infiltrates. AIH may present with features of other autoimmune liver conditions or overlap syndromes. AIH responds promptly to immunosuppression therapy including corticosteroids (prednis(ol)one or budesonide) with azathioprine. Joint care between primary healthcare and hepatology services is required to monitor treatment efficacy, adverse effects and signs of progressive cirrhosis and liver failure.

    • Research article

      Thrombotic microangiopathies and the kidney

      Medicine, Volume 43, Issue 9, 2015, pp. 529-532

      Thrombotic microangiopathies are rare and carry a high morbidity and mortality. Recent research has helped to clarify their aetiology. A high index of suspicion is required in patients presenting with renal impairment and features of microangiopathy such as a low platelet count and Coomb's test-negative haemolytic anaemia. In Shiga toxin-mediated haemolytic—uraemic syndrome (HUS), bacteria such as Escherichia coli O157 adhere to the intestinal mucosa, and secrete a highly potent Shiga cytotoxin, which binds to the glomerular endothelium and causes an endotheliopathy. In atypical HUS, the alternative pathway of complement, in the absence of an intact regulatory system, runs out of control. The endothelium is the predominant target, in a variety of organs including the kidneys, brain and heart. In thrombotic thrombocytopenic purpura, dysfunction of an enzyme (ADAMTS13) that cleaves and inactivates ultra-large multimers of von Willebrand factor leads to the formation of platelet-rich thrombi. Most thrombotic microangiopathies are treatable if identified early.

    • Research article

      Immunodeficiency and thegut

      Medicine, Volume 43, Issue 5, 2015, pp. 259-261

      Gastrointestinal diseases associated with impaired immunity are largely infectious, although an increased incidence of extranodal lymphoma is also found in the context of HIV infection. The range of such infections is related to the role of CD4-positive T cells in their eradication. Infections tend to occur with organisms of limited virulence and to be recurrent, and are associated with disseminated infection. The symptoms they produce are usually pain on swallowing, weight loss or diarrhoea. Abdominal pain may be associated with Mycobacterium avium intracellulare (MAI) or sclerosis of the bile ducts secondary to infection.

    • Research article

      Gout of the axial joint—A patient level systemic review

      Seminars in Arthritis and Rheumatism, Volume 48, Issue 4, 2019, pp. 649-657

      Gout is the osteoarticular expression of hyperuricemia, resulting from excessive production and/or insufficient elimination of uric acid. Emerging case reports described the deposition of mono sodium urate in the spine as a rare manifestation of gout, we aimed in revealing the full picture of reported axial joint gout (AJG).

      We performed a systemic patient level review focused on characteristics of reported cases of axial joint involvement in gout.

      A total of 127 studies (142 cases) were identified as axial joint gout. Most of the cases were reported by neurosurgeons and orthopedic surgeons (19.7% and 17.6%, respectively),low back and neck pain and weakness of limbs were presented in 113 cases, most of the cases (77.5%) were diagnosed via operation or aspiration. Although CT and MRI was the most popular imaging method, 8 cases underwent DECT avoided surgery had marked improvement.

      The incidence of AJG was underestimated and the IAJG exist independent of peripheral arthritis. AJG should be suspected when back pain and neurological involvement occurred in the risky populations. DECT would be a promising technique to initiate the earlier intervention complimentary to invasive procedures or operations.

      (Video) Gout: Visual Explanation for Students

    View full text

    Copyright © 1994 Published by Mosby, Inc.

    FAQs

    Can crystals cause arthritis? ›

    Calcium pyrophosphate deposition (CPPD) disease, commonly called “pseudogout,” is a painful form of arthritis that comes on suddenly. It occurs when calcium pyrophosphate crystals sit in the joint and surrounding tissues and cause symptoms like gout. Gout, however, is caused by a different type of crystal.

    How do you get rid of crystals in your joints? ›

    Tips for relieving pain from gout crystals
    1. apply ice to your joint.
    2. elevate your affected joint.
    3. get a good night's rest.
    4. drink plenty of water.
    5. avoid alcohol or beverages high in sugar.
    6. avoid seafood, red meat, and other foods high in purines.
    Aug 24, 2021

    What is crystal induce arthritis? ›

    Crystal-induced arthritis (CIA) comprises two main inflammatory arthropathies, gout, and pseudogout, characterized by the formation and deposition in joints of monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals, respectively.

    What crystal is consistent with long term rheumatoid arthritis? ›

    Calcium pyrophosphate crystals often are found in the cartilage and even synovial fluids of older people who have no symptoms. Many people who have these crystal deposits will never have acute gout-like attacks or chronic arthritis.

    Can too much calcium cause arthritis? ›

    It's not possible to get calcific tendonitis or calcific periarthritis by eating too much calcium. It's important to have calcium in your diet, because it can reduce the chances of osteoporosis, a condition which causes bones to become thin and to fracture.

    How do you get rid of gout crystals? ›

    Too much alcohol may raise your uric acid level and bring on a gout episode. Drink at least 10-12 eight-ounce glasses of non-alcoholic fluids daily, especially if you have had kidney stones. This will help flush the uric acid crystals out of your body.

    Can massage break up gout crystals? ›

    It can be! As gout is inflammatory, the anti-inflammatory relief massage may bring can be immensely helpful. Different types of massage techniques such as Thai massage and those aimed at helping flush toxins from your body are most beneficial when getting a massage for gout.

    How long does it take for gout crystals to dissolve? ›

    The lower your uric acid level, the faster gout buildup dissolves. It can take more than 2 years for oral gout medicines to dissolve even a small amount of uric acid crystal buildup. KRYSTEXXA can dissolve most of it in about 6 months.

    Can ultrasound break up gout crystals? ›

    Ultrasound has been shown to be a sensitive method to detect uric monosodium urate (MSU) deposition and its use is included in the classification criteria for gout.

    What does crystals in the knee mean? ›

    Many people with osteoarthritis, particularly of the knee, have these calcium crystals in their joint cartilage. This is called osteoarthritis with calcium pyrophosphate crystal deposition (osteoarthritis with CPPD for short) and the symptons tend to be worse than osteoarthritis without crystals.

    Does calcium affect arthritis? ›

    Deposition of calcium pyrophosphate dihydrate (CPPD) causes this form of arthritis. The buildup of this chemical forms crystals in the cartilage of joints. This leads to attacks of joint swelling and pain in the knees, wrists, ankles, shoulders and other joints.

    What foods should I avoid with pseudogout? ›

    In the case of gout and pseudogout which are affected by the metabolic factor of the body, it is best to avoid high-purine food like red meat and shellfish. Drinking beer and soda can also elevate the level of uric acid which may worsen the pain and discomfort in joints.

    What can be mistaken for rheumatoid arthritis? ›

    Conditions That Can Look Like RA
    • Lyme Disease.
    • Psoriatic Arthritis.
    • Sjögren's Syndrome.
    • Gout.
    • Fibromyalgia.
    • Lupus.
    Sep 24, 2020

    Can you test positive for RA and not have it? ›

    Since RA is an autoimmune disease, many people with RA have positive ANA tests. However, a positive test doesn't mean you have RA. Many people have positive, low-level ANA tests without clinical evidence of RA.

    What causes calcium build up around joints? ›

    Reduce salt intake – Too much sodium in your diet can cause high blood pressure. High blood pressure weakens the walls of the arteries and makes it more likely for calcium to build up in this area. Exercise – This helps to decrease calcium buildup as well as cholesterol levels.

    What vitamin deficiency causes arthritis? ›

    Reduced vitamin D intake has been linked to increased susceptibility to the development of rheumatoid arthritis (RA) and vitamin D deficiency has been found to be associated with disease activity in patients with RA.

    Which vitamin is good for joint pain? ›

    Vitamin D is important for keeping bones strong and preventing injuries from falls. Research shows that people with low levels of vitamin D may have more joint pain.

    What vitamin is good for joint lubrication? ›

    Glucosamine/Chondroitin for Joint Pain. Glucosamine is found naturally in the body's joint cartilage -- helping keep it healthy and lubricated. The shells of shrimp, lobster, and crab provide the basis for these supplements.

    Does lemon juice break down uric acid? ›

    A 2017 study found that lemon juice and lemon extract helped lower uric acid levels in the blood. Adults with high uric acid levels drank freshly squeezed lemon juice (equivalent to a lemon a day) every day for 6 weeks.

    What removes uric acid from the body? ›

    Normally, your body filters out uric acid through your kidneys and in urine. If you consume too much purine in your diet, or if your body can't get rid of this by-product fast enough, uric acid can build up in your blood. A high uric acid level is known as hyperuricemia.

    What type of massage is best for arthritis? ›

    Any type of full-body massage therapy that involves moderate pressure, including self-massage, should help relieve arthritis pain and ease tension, she says.

    Does heat melt gout crystals? ›

    The key hypothesis is that these urate crystals dissolve on warming. Hence, by warming the joint concerned in hot water, and moving the joint around to encourage diffusion, the urate concentration is reduced and crystals no longer form, provided the treatment is continued.

    How should you sleep with gout? ›

    Rest. If your gout is acting up, one of the best things you can do is ease the pressure on the joint until you feel better. Try elevating the affected joint on a pillow or bunched-up blanket, which can help reduce swelling.

    Which food can reduce uric acid? ›

    Top 10 foods to control uric acid
    • Green Tea Green tea is rich with high catechin content which is a potent antioxidant. Catechin, as believed by many, is used to slow down the production of particular type of enzymes in the body. ...
    • Fibre. ...
    • Vitamin C. ...
    • Cherries. ...
    • Water or fluids. ...
    • Berries. ...
    • Fruits and tomatoes. ...
    • Vegetables.
    Apr 16, 2021

    What is the best thing to drink if you have gout? ›

    Water. Drinking plenty of water is best if you have gout. Other beverages recommended for gout patients include milk, tart cherry juice, and coffee—all in moderation.

    Does baking soda help gout? ›

    In a 2020 study, researchers found that people consuming sodium bicarbonate showed no changes in their uric acid levels after a 20-week intervention. If a person wants to drink baking soda to treat gout, they can dissolve half a teaspoon of baking soda in water. They can do this multiple times per day.

    Does gout ever go away completely? ›

    Your symptoms don't get any better after 48 hours or don't end after about a week. If you don't start to feel somewhat better after a few days, call your doctor. They may suggest a different treatment. Most gout attacks will go away by themselves in several weeks, even without treatment.

    Can uric acid crystals be seen on MRI? ›

    There are several characteristic ultrasound imaging findings, which include visualiza- tion of echogenic monosodium urate crystal deposition, tophus, and adjacent erosions. MRI is sensitive in showing soft-tissue and osseous abnormalities of gout, although the imaging findings are not specific.

    Is gout a lifelong condition? ›

    Since the treatment for gout is lifelong, it's very important to make a definitive diagnosis. Ideally, the diagnosis is made by identifying uric acid crystals in joint fluid or in a mass of uric acid (tophus).

    Should I take calcium for osteoarthritis? ›

    It's smart to check with your doctor about your individual needs, but most people with arthritis should meet the same RDA for calcium as healthy adults. For women 19 to 50 years old the RDA is 1000 mg; those older than 50 should get 1,200 mg a day.

    What is arthritis made of? ›

    In rheumatoid arthritis, the body's immune system attacks the lining of the joint capsule, a tough membrane that encloses all the joint parts. This lining (synovial membrane) becomes inflamed and swollen. The disease process can eventually destroy cartilage and bone within the joint.

    Can low calcium cause arthritis? ›

    Milk is an excellent source for calcium which is important for bone formation. However, a low calcium diet is known to increase one's chance of getting osteoporosis, not osteoarthritis. Calcium intake is not directly associated with the onset of osteoarthritis.

    What deficiency causes joint pain? ›

    Severe lack of vitamin D causes rickets, which shows up in children as incorrect growth patterns, weakness in muscles, pain in bones and deformities in joints. This is very rare. However, children who are deficient in vitamin D can also have muscle weakness or sore and painful muscles.

    Does calcium and vitamin D help arthritis? ›

    Vitamin D is critical for overall health. For one, it helps with calcium absorption, which in turn helps the body develop and maintain healthy bones. It also reduces inflammation and plays a role in regulating the immune system, so the body is better able to ward off sickness and disease, including arthritis.

    What supplements can cause joint pain? ›

    However, fat-soluble vitamins and certain minerals aren't easily eliminated and can accumulate to unhealthy levels if you take too much. For example, too much iron causes joint pain, according to the Arthritis Foundation. Avoid taking more than the recommended daily allowance of any vitamin or mineral.

    What is the best natural treatment for pseudogout? ›

    To cope with pseudogout I recommend changing your diet to eliminate foods that favor inflammation. These include polyunsaturated vegetable oils, and all sources of trans-fatty acids, such as margarine and partially hydrogenated vegetable oils.

    What is the best medication for pseudogout? ›

    If you have frequent episodes of pseudogout, your doctor may recommend that you take colchicine daily as a preventive measure. Corticosteroids. If you can't take NSAIDs or colchicine, your doctor may suggest taking corticosteroid pills, such as prednisone, to reduce inflammation and end the attack.

    Does magnesium help pseudogout? ›

    1998], magnesium supplementation has often been recommended as a safe prophylactic agent to decrease the frequency of acute attacks of pseudogout.

    Why do I suddenly have arthritis? ›

    The most common triggers of an OA flare are overdoing an activity or trauma to the joint. Other triggers can include bone spurs, stress, repetitive motions, cold weather, a change in barometric pressure, an infection or weight gain. Psoriatic arthritis (PsA) is an inflammatory disease that affects the skin and joints.

    Where does RA usually start? ›

    The most commonly affected areas during the onset of RA are the small joints in your hands and feet. This is where you may first feel stiffness and an ache. It's also possible for RA inflammation to affect your knees and hips.

    Can blood tests detect rheumatoid arthritis? ›

    No blood test can definitively prove or rule out a diagnosis of rheumatoid arthritis, but several tests can show indications of the condition. Some of the main blood tests used include: erythrocyte sedimentation rate (ESR) – which can help assess levels of inflammation in the body.

    What blood markers indicate RA? ›

    People with rheumatoid arthritis often have an elevated erythrocyte sedimentation rate (ESR, also known as sed rate) or C-reactive protein (CRP) level, which may indicate the presence of an inflammatory process in the body.

    Is RA a disability? ›

    The Social Security Administration (SSA) considers RA a disability if a person meets the following eligibility criteria: the person's condition is so severe that they will need to be out of work for 12 months or more. the person has gained enough work credits to qualify for disability benefits.

    What does RA pain feel like? ›

    A person with RA may feel intense pain in their joints during flares. This may feel like sustained pressure, a burning sensation, or a sharp pain. However, people with RA may also experience periods of remission when they feel few to no symptoms. In addition to causing pain in the joints, RA can affect the whole body.

    How do you get rid of crystals in your joints? ›

    There's no treatment available to dissolve the crystal deposits, but a combination of treatments can relieve pain and inflammation and improve joint function. Treatment often includes medications such nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids.

    What dissolves calcium in the body? ›

    Apple Cider Vinegar

    The vinegar dissolves the misplaced calcium and even restores the natural balance of nutrients in the body. Drink at least 1 tablespoon of ACV diluted in 8 ounces of water daily.

    How do you dissolve calcium build up in the body? ›

    Eat a balanced diet composed of all essential nutrients. Exercise can decrease the buildup calcium and cholesterol inside the artery. Exercise burns body fat and it also does not allow the fat to stay for a long time in the blood. Reduce your sodium intake.

    What causes crystallization in the body? ›

    Sometimes, eating a diet too high in protein or salt can cause urine crystals to form. Dehydration from not drinking enough fluids can also lead to the formation of urine crystals. In some cases, an underlying health condition may cause urine crystals, and the person will need treatment for the condition.

    What causes crystals in your feet? ›

    More specifically, when there is an excess of uric acid in the blood, it can begin to form tiny crystals in and around joints. These crystals are hard, needle-shaped, and build up slowly over time. When some of them spill over into the synovium, which lines the joints, they bring about pain and inflammation.

    What causes crystals in knees? ›

    The cause of abnormal deposits of CPPD crystals in cartilage is often unknown. CPPD crystals may be seen associated with some underlying disorders such as injury to the joint, hyperparathyroidism, hypomagnesemia, hypophosphatasia, hypothyroidism and hemochromatosis.

    What does crystals in knee fluid mean? ›

    Pseudogout is a type of arthritis that causes spontaneous, painful swelling in your joints. It occurs when crystals form in the synovial fluid, the fluid that lubricates the joints. This leads to inflammation and pain. This condition most often affects the knees, but it can affect other joints as well.

    How do you treat crystals? ›

    1. Running water. Water is said to neutralize any negative energy stored inside the stone and return it back to the earth. Although natural running water — like a stream — is best, you can also rinse your stone under a faucet.

    How can I test my crystals? ›

    You can test if your crystals have been dyed by: Dabbing nail polish remover on a cotton bud and wiping this on the crystal. If the cotton bud has colour on it from the crystal, and the crystal now has a paler spot, then you probably have a dyed crystal.

    Can crystals grow in your body? ›

    One lesson the Estroff Group has learned from biology is that often these crystals grow in special spaces within the organism's body. “The crystals are not growing willy nilly anywhere in the organism, but rather the organism uses biological macromolecules to define a space in which they grow,” Estroff explains.

    Videos

    1. Crystal Arthritis (Gout and Pseudogout) | Flow Rheumatology | Scottsdale, Arizona
    (Flow Rheumatology)
    2. Gout and pseudogout | Muscular-skeletal diseases | NCLEX-RN | Khan Academy
    (khanacademymedicine)
    3. Crystal Arthropathies
    (Icahn School of Medicine)
    4. Women Try Crystal Healing For Chronic Pain
    (As/Is)
    5. Advanced Imaging for Crystal Arthritis: Which Test is Best? Dr. Nicola Dalbeth
    (RheumNow)
    6. Crystals For Pain
    (Rock'n Crystals)

    You might also like

    Latest Posts

    Article information

    Author: Foster Heidenreich CPA

    Last Updated: 09/30/2022

    Views: 6248

    Rating: 4.6 / 5 (76 voted)

    Reviews: 83% of readers found this page helpful

    Author information

    Name: Foster Heidenreich CPA

    Birthday: 1995-01-14

    Address: 55021 Usha Garden, North Larisa, DE 19209

    Phone: +6812240846623

    Job: Corporate Healthcare Strategist

    Hobby: Singing, Listening to music, Rafting, LARPing, Gardening, Quilting, Rappelling

    Introduction: My name is Foster Heidenreich CPA, I am a delightful, quaint, glorious, quaint, faithful, enchanting, fine person who loves writing and wants to share my knowledge and understanding with you.